Literature DB >> 36268250

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy.

Kauzshi Numata1, Feiqian Wang2.   

Abstract

Entities:  

Year:  2022        PMID： 36268250      PMCID： PMC9577998          DOI： 10.21037/hbsn-22-363

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  10 in total

1.  Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.

Authors:  Hiroyuki Fukuda; Kazushi Numata; Satoshi Moriya; Yu Shimoyama; Tomohiro Ishii; Akito Nozaki; Masaaki Kondo; Manabu Morimoto; Shin Maeda; Kentaro Sakamaki; Satoshi Morita; Katsuaki Tanaka
Journal:  Radiology       Date:  2014-04-02       Impact factor: 11.105

2.  Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.

Authors:  Koji Hara; Atsuya Takeda; Yuichiro Tsurugai; Yusuke Saigusa; Naoko Sanuki; Takahisa Eriguchi; Shin Maeda; Katsuaki Tanaka; Kazushi Numata
Journal:  Hepatology       Date:  2019-05-02       Impact factor: 17.425

3.  Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Yudai Tateishi; Yuichiro Tsurugai; Naoko Sanuki; Hirotoshi Ebinuma; Nobuyuki Horita
Journal:  Hepatol Res       Date:  2021-05-05       Impact factor: 4.288

4.  Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.

Authors:  Xiaobin Feng; Ruocai Xu; Xilin Du; Kefeng Dou; Xiao Qin; Jun Xu; Weidong Jia; Zhiming Wang; Hongzhi Zhao; Shufa Yang; Chenyang Guo; Tianqi Liu; Kuansheng Ma
Journal:  Am J Gastroenterol       Date:  2014-11-18       Impact factor: 10.864

5.  Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.

Authors:  X Kan; Y Jing; Q-Y Wan; J-C Pan; M Han; Y Yang; M Zhu; Q Wang; K-H Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

6.  Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh Class A Liver function: A Pilot Study.

Authors:  Feiqian Wang; Kazushi Numata; Satoshi Komiyama; Haruo Miwa; Kazuya Sugimori; Katsuaki Ogushi; Satoshi Moriya; Akito Nozaki; Makoto Chuma; Litao Ruan; Shin Maeda
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

Review 7.  A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis.

Authors:  Tan To Cheung; Ka Wing Ma; Wong Hoi She
Journal:  Hepatobiliary Surg Nutr       Date:  2021-04       Impact factor: 8.265

8.  Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4-B1: a pilot study.

Authors:  Feiqian Wang; Kazushi Numata; Atsuya Takeda; Katsuaki Ogushi; Hiroyuki Fukuda; Hiromi Nihonmatsu; Koji Hara; Makoto Chuma; Yuichirou Tsurugai; Shin Maeda
Journal:  BMC Cancer       Date:  2021-10-30       Impact factor: 4.430

9.  Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation.

Authors:  Quanyou Gong; Zhaoxia Qin; Fangli Hou
Journal:  Oncol Lett       Date:  2017-10-12       Impact factor: 2.967

10.  Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound.

Authors:  Zhen Xu; Timothy L Hall; Eli Vlaisavljevich; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2021       Impact factor: 3.753
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.